Cotiviti, a top company in healthcare data solutions, has appointed Robert Kopanic as its new Chief Revenue Officer to help the company grow as it expands its services. Kopanic has more than 25 years of experience in healthcare technology and leadership. In this role, he will lead the sales and client engagement teams.
Health Technology Insights: Alpha Aesthetics Grows with New Clinic in Bonita Springs
Emad Rizk, M.D., chairman, president, and CEO of Cotiviti, highlighted the company’s focus on innovation and providing value to clients. “Since our acquisition of Edifecs, we’ve entered a new stage of growth, powered by advanced technology and valuable insights. Our ability to connect payers and providers puts us in a unique position to address both medical and administrative cost issues,” said Dr. Rizk. “Bob’s wide experience and solid relationships with clients make him the perfect leader to help us achieve our mission and grow.”
Before joining Cotiviti, Kopanic was the head of North America healthcare sales at Oracle Health, where he helped increase revenue and managed the integration after a merger. He has also spent 14 years at Philips Corporation in leadership roles across sales, operations, and new business areas. He is also a former U.S. Air Force veteran.
Health Technology Insights: Canary Speech Names Dr. Kang Hsu Jr. as Chief Medical Officer
Kopanic said, “Cotiviti’s success is based on innovation and delivering value with integrity. As Chief Revenue Officer, I am committed to being a transparent and solution-focused partner for our clients. I look forward to working closely with our skilled sales and client engagement teams to better serve our customers.”
Reporting directly to Dr. Rizk, Kopanic joins Cotiviti’s top leadership team and will work with business leaders across Cotiviti and Edifecs. His main goal is to drive growth in important areas like payment integrity, quality improvement, risk adjustment, engagement, interoperability, and value-based care.
Health Technology Insights: FDA Approves BRINSUPRI for Non-Cystic Fibrosis Bronchiectasis Treatment
To participate in our interviews, please write to our HealthTech Media Room at sudipto@intentamplify.com
